Leah Rahman

TL;DR: What is known about the SARS-CoV-2-induced cellular senescence and iron dysmetabolism is summarized and a closer look at immunotherapy with natural killer cells, angiotensin II receptor blockers, iron chelators and dipeptidyl peptidase 4 inhibitors as adjunct treatments for both COVID-19 and its neurodegenerative complications are taken.

TL;DR: In this paper, the authors take a closer look at the virus-host dialog and its impact on the renin-angiotensin system, mitochondrial fitness, and brain-derived neurotrophic factor.

TL;DR: In this paper , the role of intestinal and blood-brain barriers in long COVID and other illnesses typified by chronic fatigue, with a special emphasis on commensal microbes functioning as viral reservoirs.

TL;DR: The messenger RNA (mRNA) vaccines for COVID-19, Pfizer-BioNTech and Moderna, were authorized in the US on an emergency basis in December of 2020 and form the vanguard of a range of other mRNA therapeutics that are currently in the development pipeline, focusing both on infectious diseases as well as oncological applications.

TL;DR: The authors hypothesize that many remaining idiopathic conditions, including fibroproliferative, and neuropsychiatric diseases as well as some cancers, can be considered microbial translocation disorders triggered by the host immune responses to extraintestinal gut microbes and/or their constituent parts.